NYSE:ATNM

Actinium Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy ATNM

*Your capital is at risk

$1.11

-0.0500 (-4.31%)

At Close: Jun 04, 2026

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

11:00am, Thursday, 03'rd Oct 2024

LOS ANGELES, CA / ACCESSWIRE / October 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc's Possible Securities Fraud

11:00am, Wednesday, 02'nd Oct 2024

LOS ANGELES, CA / ACCESSWIRE / October 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Stockholders With Losses Are Urged To Contact The Schall Law Firm

11:00am, Tuesday, 01'st Oct 2024

LOS ANGELES, CA / ACCESSWIRE / October 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharma

The Schall Law Firm Invites Investors To Join An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

11:00am, Monday, 30'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Impacted Stockholders Are Urged To Reach Out To The Schall Law Firm

11:00am, Sunday, 29'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

11:00am, Sunday, 29'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM). Such investo

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

11:00am, Saturday, 28'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

01:45pm, Friday, 27'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM). Such investor

Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Impacted Stockholders Are Urged To Contact The Schall Law Firm

11:00am, Friday, 27'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

11:00am, Thursday, 26'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

03:58pm, Wednesday, 25'th Sep 2024

NEW YORK , Sept. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM).

Actinium Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

11:00am, Wednesday, 25'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

The Schall Law Firm Invites Investors To Join A Securities Fraud Inquiry Into Actinium Pharmaceuticals Inc

11:00am, Tuesday, 24'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

12:15am, Tuesday, 24'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM). Such investor

Actinium Pharmaceuticals, Inc. Is Being Investigated By The Schall Law Firm For Violating Securities Laws And Shareholders Should Reach Out

11:00am, Monday, 23'rd Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by